Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001164
First received: November 3, 1999
Last updated: March 4, 2008
Last verified: June 2000
  Purpose

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.


Condition
Healthy
Muscular Dystrophy
Retinal Degeneration
Skin Diseases
Virus Diseases

Study Type: Observational
Official Title: Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Study Start Date: July 1978
Estimated Study Completion Date: June 2000
Detailed Description:

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Patients with skin diseases of presumed genetic, immunologic, or virologic origin are eligible.

Patients with neurological degenerations are eligible, including patients with inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such inherited diseases.

Volunteers without skin diseases are eligible, except children.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001164

Locations
United States, Maryland
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00001164     History of Changes
Other Study ID Numbers: 780099, 78-C-0099
Study First Received: November 3, 1999
Last Updated: March 4, 2008
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Genetic Evaluation
Immunologic Evaluations
Inflammatory Skin Disease
Muscular Dystrophies
Neoplastic Skin Diseases
Neuronal Degenerations
Retinal Degenerations
Viral Diseases

Additional relevant MeSH terms:
Retinal Degeneration
Muscular Dystrophies
Skin Diseases
Virus Diseases
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn
Retinal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on September 18, 2014